Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04720430 · ClinicalTrials.gov registry record
Blood Sample Collection for Experimental Blood Test to Track Liver Cancer
A clinical trial, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 7
- Enrollment target
NCT04720430: Completed study, sponsored by Thomas Jefferson University.
NCT04720430 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04720430 has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
This study investigates if an experimental blood test can help predict how well cancer will remain under control with treatment. Ther experimental blood test involves measuring mircoRNAs. MicroRNAs are small molecules which help regulate how genes are expressed. This information may help researchers guide treatment for other patients in the future.
Primary Outcome
Undergoing liver transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-12-03 |
| Est. Completion | 2023-11-09 |
What the finished NCT04720430 record still lists
NCT04720430 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04720430 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04720430 about?
NCT04720430 is a clinical study titled "Blood Sample Collection for Experimental Blood Test to Track Liver Cancer". This study investigates if an experimental blood test can help predict how well cancer will remain under control with treatment. Ther experimental blood test involves measuring mircoRNAs. MicroRNAs are small molecules which help regulate how genes are expressed. This information may help researchers...
What is the current status of trial NCT04720430?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2019-12-03. Estimated completion is 2023-11-09.
Who is sponsoring clinical trial NCT04720430?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI